Narcolepsy-cataplexy and schizophrenia in adolescents

Sleep Medicine

Volumn 15, Issue 1, 2014, Pages 15-22

  Huang, Yu Shu ^a   Guilleminault, Christian ^b   Chen, Chia Hsiang ^a,c,d   Lai, Ping Chin ^a   Hwang, Fan Ming ^e  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b STANFORD UNIVERSITY   (United States)

^c TZU CHI UNIVERSITY   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e NATIONAL CHIAYI UNIVERSITY   (Taiwan)

Author keywords

Adolescent; Cataplexy; Chinese and HLA DQ B1 03:01; HLA; Narcolepsy; Schizophrenia

Indexed keywords

HLA ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; METHYLPHENIDATE; MODAFINIL; NEUROLEPTIC AGENT; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VENLAFAXINE;

ADOLESCENT; AGE; ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; BLOOD ANALYSIS; BODY MASS; BODY WEIGHT; CASE CONTROL STUDY; CATAPLEXY; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DSM-IV; EPWORTH SLEEPINESS SCALE; FEMALE; GENETIC ANALYSIS; HLA TYPING; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NARCOLEPSY; ONSET AGE; PEDIATRIC DAYTIME SLEEPINESS SCALE; POLYSOMNOGRAPHY; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; RISK FACTOR; SCHEDULE FOR AFFECTIVE DISORDER AND SCHIZOPHRENIA; SCHIZOPHRENIA; SEX RATIO; SLEEP; STANFORD NARCOLEPSY QUESTIONNAIRE; TREATMENT RESPONSE;

ADOLESCENT; CATAPLEXY; CHINESE AND HLA DQ B1-03:01; HLA; NARCOLEPSY; SCHIZOPHRENIA;

ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHILD; COMORBIDITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; MALE; NARCOLEPSY; OREXIN RECEPTORS; POLYSOMNOGRAPHY; RETROSPECTIVE STUDIES; RISK FACTORS; SCHIZOPHRENIA; TAIWAN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84891630436     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2013.09.018     Document Type: Article

References (50)

1. De la Gélineau J. Narcolepsie. Gaz Hop (Paris) 1880, 53. 626-8, 635-737.
2. Guilleminault C., Dement W.C., Passouant P. Narcolepsy 1976, Spectrum Publications, New York.
3. *0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 1997, 20:1012-1020.
4. Mignot E. Narcolepsy: pathophysiology and genetic predisposition. Principles and practice of sleep medicine 2011, 939. Elsevier-Sauders, Saint Louis (MO). 5th ed. M.H. Kryeger, T. Roth, W.C. Dement (Eds.).
5. Blouin A.M., Thannickal T.C., Worley P.F., Baraban J.M., Reti I.M., Siegel J.M. Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy. Neurology 2005, 65:1189-1192. [published online ahead of print August 31, 2005].
6. Hallmayer J., Faraco J., Lin L., Hesselson S., Winkelmann J., Kawashima M., et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 2009, 41:708-711. [published online ahead of print May 3, 2009].
7. Douglass A.B., Shipley J.E., Haines R.F., Scholten R.C., Dudley E., Tapp A., et al. Schizophrenia, narcolepsy, and HLA-DR15, DQ6. Biol Psychiatry 1993, 34:773-780.
8. Wilson J. Psychopathology and narcolepsy. Neuropsychobiology 1985, 14:170-172.
9. Kishi Y., Konishi S., Koizumi S., Kudo Y., Kurosawa H., Kathol R.G. Schizophrenia and narcolepsy: a review with a case report. Psychiatry Clin Neurosci 2004, 58:117-124.
10. Talih F.R. Narcolepsy presenting as schizophrenia: a literature review and two case reports. Innov Clin Neurosci 2011, 8:30-34.
11. Kadasah S., Arfin M., Tariq M. HLA-DRB1 association with schizophrenia in Saudi Arabian patients. Int J Psychiatry Clin Pract 2011, 15:112-117. [published online ahead of print November 30, 2010].
12. Auger R.R., Goodman S.H., Silber M.H., Krahn L.E., Pankratz V.S., Slocumb N.L. Risks of high-dose stimulants in the treatment of disorders of excessive somnolence: a case-control study. Sleep 2005, 28:667-672.
13. Krause D., Wagner J., Matz J., Weidinger E., Obermeier M., Riedel M., et al. Monocytic HLA DR antigens in schizophrenic patients. Neurosci Res 2012, 72:87-93. [published online ahead of print September 22, 2011].
14. Schwab S.G., Hallmayer J., Freimann J., Lerer B., Albus M., Borrmann-Hassenbach M., et al. Investigation of linkage and association/linkage disequilibrium of HLA A-, DQA-, DQB1-, and DRB1-alleles in 69 sib-pairs and 89 trio-families with schizophrenia. Am J Med Genet 2002, 114:315-320.
15. Debnath M., Cannon D.M., Venkatasubramanian G. Variation in the major histocompatibility complex (MHC) gene family in schizophrenia: associations and functional implications. Prog Neuropsychopharmacol Biol Psychiatry 2013, 42:49-62. [published online ahead of print July 17, 2012].
16. American Academy of Sleep Medicine The international classification of sleep disorders: diagnostic and coding manual 2005, American Academy of Sleep Medicine, Westchester (IL). 2nd ed.
17. Yang C.M., Huang Y.S., Song Y.C. Clinical utility of the Chinese version of the Pediatric Daytime Sleepiness Scale in children with obstructive sleep apnea syndrome and narcolepsy. Psychiatry Clin Neurosci 2010, 64:134-140.
18. Chen N.H., Johns M.W., Li H.Y., Chu C.C., Liang S.C., Shu Y.H., et al. Validation of a Chinese version of the Epworth Sleepiness Scale. Qual Life Res 2002, 11:817-821.
19. Anic-Labat S., Guilleminault C., Kraemer H.C., Meehan J., Arrigoni J., Mignot E. Validation of a cataplexy questionnaire in 983 sleep-disorders patients. Sleep 1999, 22:77-87.
20. Guilleminault C., Wilson R., Dement W.C. A study on cataplexy. Arch Neurol 1974, 31:255-261.
21. Orraschel H., Puig-Antich J. Schedule for affective disorders and schizophrenia for school-age children: epidemiologic 1987, Nova University, Center for Psychological Study, Ft. Lauderdale (FL). 4th ed.
22. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington (DC), Text Revision. 4th ed.
23. Kay S.R. Positive and negative syndromes in schizophrenia 1991, Brunner-Mazel, New York (NY).
24. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
25. Beck A.T., Epstein N., Brown G., Steer R.A. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988, 56:893-897.
26. Iber C., Ancoli-Israel S., Chesson A., Quan S.F. The American academy of sleep medicine manual for the scoring of sleep and associated events: rules, terminology and technical specifications 2007, Academy of Sleep Medicine, Westchester (IL).
27. Hori T., Sugita Y., Koga E., Shirakawa S., Inoue K., Uchida S., et al. Sleep Computing Committee of the Japanese Society of Sleep Research Society. Proposed supplements and amendments to 'A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects', the Rechtschaffen & Kales (1968) Standard. Psychiatry Clin Neurosci 2001, 55:305-310.
28. EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992, 15:173-184.
29. Guilleminault C., Pelayo R. Narcolepsy in pre-pubertal children. Ann Neurol 1998, 43:135-142.
30. Serra L., Montagna P., Mignot E., Lugaresi E., Plazzi G. Cataplexy features in childhood narcolepsy. Mov Disord 2008, 23:858-865.
31. Huang Y.S., Tafti M., Guilleminault C. Daytime sleepiness with and without cataplexy in Chinese-Taiwanese patients. Sleep Med 2006, 7:454-457.
32. Cazuello C.L., Simeraldi E., Penati G. The leucocyte antigenic system HLA-A as possible genetic marker of schizophrenia. Br J Psychiatry 1974, 125:612-615.
33. Benros M.E., Nielsen P.R., Nordentoft M., Eaton W.W., Dalton S.O., Mortensen P.B. Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am J Psychiatry 2011, 168:1303-1310.
34. Chen S.J., Chao Y.L., Chen C.Y., Chang C.M., Wu E.C.H., Wu C.S., et al. Prevalence of autoimmune diseases in in-patients with schizophrenia: nation-wide population-based study. Br J Psychiatry 2012, 200:374-380. [published online ahead of print March 22, 2012].
35. Grosskopf A., Müller N., Malo A., Wank R. Potential role for the narcolepsy and multiple sclerosis associated HLA allele in schizophrenia subtypes. Scizophr Res 1998, 30:187-189.
36. Carter C.J. Schizophrenia: a pathogenetic autoimmune disease caused by viruses and pathogens and dependent on genes. J Pathog 2011, 2011:128318. [published online ahead of print May 26, 2011].
37. Wu Z.P., Washburn L., Bilousova T.V., Boudzinskaia M., Escande-Beillard N., Querubin J., et al. Enhanced neuronal expression of major histocompatibility complex class I leads to aberrations in neurodevelopment and neurorepair. J Neuroimmunol 2011, 232:8-16. [published online ahead of print October 14, 2010].
38. Ikeda M., Aleksic B., Yamada K., Iwayama-Shiegeno Y., Matsuo K., Numata S., et al. Genome-wide association study of schizophrenia in a Japanese population. Biol Psychiatry 2011, 65:472-478.
39. Monji A., Kato T., Mizoguchi Y., Horikawa H., Seki Y., Kasai M., et al. Neuroinflammation in schizophrenia especially focused on the role of microglia. Prog Neuropsychopharmacol Biol Psychiatry 2013, 42:115-121. [published online ahead of print December 13, 2011].
40. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?. J Psychiatr Res 1982, 17:319-334.
41. Escande-Beillard N., Washburn L., Zekzer D., Wu Z.P., Eitan S., Ivkovic S., et al. Neurons preferentially respond to self MHC class I allele products regardless of peptide presented. J Immunol 2010, 184:816-823. [published online ahead of print December 16, 2009].
42. Feinberg I., Campbell I.G. Longitudinal sleep EEG trajectories indicate complex patterns patterns of adolescent brain maturation. Am J Physiol Regul Integr Comp Physiol 2012, 304:R296-R303. [published online ahead of print November 28, 2012].
43. Mignot E., Lin L., Rogers W., Honda Y., Qiu X., Liu X., et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 2001, 68:686-699.
44. Han F., Lin L., Li J., Dong S.X., An P., Zhao L., et al. HLA-DQ association and allele competition in Chinese narcolepsy. Tissue Antigen 2012, 80:328-335.
45. Ribstein M. Hypnagogic hallucination. Narcolepsy 1976, 145-160. John Wiley and Sons, New York (NY). C. Guilleminault, P. Passouant, W.C. Dement (Eds.).
46. Fortyun H.A., Lappenschaar G.A., Nienhuis F.J., Furer J.W., Hodiamont P.P., Rijnders C.A., et al. Psychotic symptoms in narcolepsy: phenomenology and a comparison with schizophrenia. Gen Hosp Psychiatr 2009, 31:146-154. [published online ahead of print January 24, 2009].
47. Douglass A.B., Hays P., Pazderka F., Russell J.M. Florid refractory schizophrenias that turn out to be treatable variants of HLA-associated narcolepsy. J Nerv Ment Dis 1991, 179:12-17.
48. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998, 18:9996-10015.
49. *0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. US Modafinil in Narcolepsy Multicenter Study Group. Tissue Antigen 1998, 51:96-100.
50. Nimgaonkar V.L., Ruder W.A., Zhang X.R., Tsoi W.F., Trucco M., Saha S. Further evidence for an association between schizophrenia and the HLA DQB1 gene locus. Schizophr Res 1995, 18:43-49.